Close Menu

The UK's Institute of Cancer Research is establishing a new center to focus on developing drugs to prevent cancers from evolving treatment resistance, New Scientist reports. It adds that the ICR is to provide the new center, dubbed the Centre for Cancer Drug Discovery, has £78 million ($99.8 million) in funding.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.